Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention. Read more about Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.
Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light? Read more about Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Read more about Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.
Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma. Read more about Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.
Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease. Read more about Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease.
Patient engagement in a mobile health intervention to improve preparedness for prostate biopsy. Read more about Patient engagement in a mobile health intervention to improve preparedness for prostate biopsy.
Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset. Read more about Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset.
Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy. Read more about Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy.
A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study. Read more about A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study.
Applicant perceptions of virtual interviews for society of urologic oncology fellowships during the COVID-19 pandemic. Read more about Applicant perceptions of virtual interviews for society of urologic oncology fellowships during the COVID-19 pandemic.
